Bulky, electron-rich phosphine ligands with a biphenyl backbone, when combined with Pd(OAc)2,
give highly active catalysts for the α-arylation of ketones. The ligand 2-methyl-2‘-dicyclohexylphosphinobiphenyl
is particularly effective, and with 0.1−1.0 mol % Pd, a large variety of aryl halides and ketones react efficiently
and with high selectivity. For two types of substrates, the ligands BINAP and Xantphos are more effective
than the biphenyl-based ligands. It is also shown that K3PO4 can be used as the base in these reactions, and
that base-sensitive functional groups are better tolerated if this is used instead of NaO
t
Bu or NaHMDS. In
some cases, α-aryl ketones can be produced without adding a ligand to the reaction. Although the substrate
scope of the ligandless conditions is limited, some combinations react in high yield, and in one case, 100 000
turnovers were obtained. The results of experiments on the Pd-catalyzed arylation of diethyl malonate, cyclic
1,3-diketones, and nitroalkanes are also reported.
A new catalyst system for the enantioselective alpha-arylation of ketones is reported. This catalyst, prepared from Pd(2)(dba)(3) and a bulky dialkylphosphino-binaphthyl ligand, is able to effect the asymmetric arylation of ketone enolates with aryl bromides utilizing NaO(t)()Bu as base. These new catalysts enjoy much higher reactivity than previous systems; arylation reactions could be effected at room temperature with only 2 mol % of the Pd catalyst. The coupling of alpha-alkyl-alpha'-protected cyclopentanones proceeded in high yield, and the resulting quaternary stereogenic center was installed in up to 94% ee.
[see reaction]. A protocol for the catalytic asymmetric vinylation of ketone enolates has been developed. Key to the success of this process was the development of new electron-rich chiral monodentate ligands.
Z-Vinylic tellurides, obtained with 100%
stereoselectivity by the hydrotelluration of acetylenes,
are easily transformed into Z-vinylic higher order
cyanocuprates by reaction with preformed
Me2Cu(CN)Li2,
n-Bu2Cu(CN)Li2, or
n-Bu(2-Th)Cu(CN)Li2, with
total retention of the double-bond
configuration. The resulting vinylic higher order cyanocuprates
react with unhindered enones to
give the corresponding 1,4-addition products in good yields.
Reaction of the vinylic higher order
cyanocuprates with monosubstituted epoxides at 0 °C gives the
homoallylic alcohols resulting from
the attack to the less-substituted carbon atom, while the disubstituted
epoxides failed to react.
Allylic epoxides react at −78 °C with the vinylic higher order
cyanocuprates to give mixtures of
1,2- and 1,4-opening products, the 1,4-product predominating. In
all cases the double-bond
configuration of the original vinylic telluride was preserved. The
vinylic cuprates derived from
simple vinylic tellurides and conjugated 1-telluroenynes react with
epoxides at 0 °C, while vinylic
cuprates derived from conjugated 1-tellurodienes required the addition
of 1 equiv of BF3·Et2O to
give the homoallylic alcohols on reaction with epoxides. The
opening of optically pure epoxides
through tellurium/copper transmetalation is stereospecific, giving one
single stereoisomer of the
corresponding homoallylic alcohol.
p -Methoxyphenyl)tellurium trichloride reacts with terminal acetylenes to give 1-chloro-1-organyl-2-[dichloro(p -methoxyphenyl)telluro] ethenes of Z configuration in good yields. The Z stereochemistry of the addition products suggests that the reaction occurs through a four-centered cyclic transition state. The diorganotellurium dichlorides are reduced to the corresponding tellurides with sodium borohydride.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.